Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Of 18 FDG PET In The Prediction Of Relapse In Patients With A Clinical Stage I Non-Seminomatous Germ Cell Tumor

NCT00045045 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT00045045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00045045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Of 18 FDG PET In The Prediction Of Relapse In Patients With A Clinical Stage I Non-Seminomatous Germ Cell Tumor
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2002
Completion date
July 31, 2007
Enrollment
Not reported
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

testicular germ cell tumor